|
显示项目 642376-642425 / 2348674 (共46974页)
<< < 12843 12844 12845 12846 12847 12848 12849 12850 12851 12852 > >>
每页显示[10|25|50]项目
| 臺大學術典藏 |
2018-09-10T15:39:03Z |
Oral Ulcers as an Initial Presentation of Juvenile Pemphigus: A Case Report
|
Chen, I.-H.;Mu, S.-C.;Tsai, D.;Chou, Y.-Y.;Wang, L.-F.;Wang, L.-J.; LI-FANG WANG |
| 中國醫藥大學 |
2011-05 |
Oral Uncaria rhynchophylla (UR) reduces kainic acid-induced epileptic seizures and neuronal death accompanied by attenuating glial cell proliferation and S100B proteins in rats
|
林以文(Lin Yi-Wen); 謝慶良(Ching-Liang Hsieh)* |
| 臺北醫學大學 |
2008 |
Oral Urate Transporter Plasmids by Renal Homing Nanotube Particles
|
廖嘉鴻;張淑芬 |
| 臺北醫學大學 |
2009 |
Oral Urate Transporter Plasmids by Renal Homing Nanotube Particles
|
廖嘉鴻;張淑芬 |
| 國立臺灣大學 |
1999 |
Oral Urografin in Postoperative Small Bowel Obstruction
|
陳石池; 張金堅; 王世名; 陳楷模; 林芳郁; CHEN, SHYR-CHYR; CHANG, KING-JEN; WANG, SHIH-MING; CHEN, KAI-MO; LIN, FANG-YUE |
| 臺大學術典藏 |
2018-09-10T07:20:23Z |
Oral urografin in postoperative small bowel obstruction
|
Chen, S.-C. and Chang, K.-J. and Lee, P.-H. and Wang, S.-M. and Chen, K.-M. and Lin, F.-Y.; PO-HUANG LEE; SHYR-CHYR CHEN |
| 臺大學術典藏 |
2020-03-25T02:37:08Z |
Oral urografin in postoperative small bowel obstruction
|
Lin F.-Y.;Chen K.-M.;Wang S.-M.;Lee P.-H.;Chang K.-J.;SHYR-CHYR CHEN; SHYR-CHYR CHEN; Chang K.-J.; Lee P.-H.; Wang S.-M.; Chen K.-M.; Lin F.-Y. |
| 臺大學術典藏 |
2020-11-19T03:43:14Z |
Oral urografin in postoperative small bowel obstruction
|
Chen S.-C.;Chang K.-J.;Po-Huang Lee;Wang S.-M.;Chen K.-M.;Lin F.-Y.; Chen S.-C.; Chang K.-J.; PO-HUANG LEE; Wang S.-M.; Chen K.-M.; Lin F.-Y. |
| 臺大學術典藏 |
2020-12-07T07:12:13Z |
Oral urografin in postoperative small bowel obstruction
|
SHYR-CHYR CHEN; Chang K.-J.; Lee P.-H.; Wang S.-M.; Chen K.-M.; Lin F.-Y. |
| 臺大學術典藏 |
2020-12-16T07:57:11Z |
Oral urografin in postoperative small bowel obstruction
|
Shyr-Chyr Chen;Chang K.-J.;Lee P.-H.;Wang S.-M.;Chen K.-M.;Lin F.-Y.; SHYR-CHYR CHEN; Chang K.-J.; Lee P.-H.; Wang S.-M.; Chen K.-M.; Lin F.-Y. |
| 臺大學術典藏 |
2022-08-12T06:28:55Z |
Oral urografin in postoperative small bowel obstruction
|
Chen S.-C.; KING-JEN CHANG; Lee P.-H.; Wang S.-M.; Chen K.-M.; Lin F.-Y. |
| 臺大學術典藏 |
2019-08-30T03:50:06Z |
Oral vaccination with recombinant Listeria monocytogenes expressing human papillomavirus type 16 E7 can cause tumor growth in mice to regress
|
Lin C.-W.;Lee J.-Y.;Tsao Y.-P.;Shen C.-P.;Lai H.-C.;Show-Li Chen; Lin C.-W.; Lee J.-Y.; Tsao Y.-P.; Shen C.-P.; Lai H.-C.; SHOW-LI CHEN |
| 中國醫藥大學 |
2002-02 |
Oral verruca vulgaris
|
陳玉昆(Chen YK); 薛水上; 林立民(Lin LM); 林正仲(Lin CC); (Terezhalmy GT); (Riley CK); (Moore WS) |
| 國立臺灣大學 |
2007 |
Oral Verruciform Xanthoma: A Clinicopathologic Study of 15 Cases
|
余權航; 蔡東潔; 王拯宗; 劉步遠; 王逸平; 孫安迪; 江俊斌; YU, CHUAN-HANG; TSAI, TUNG-CHIEH; WANG, JENG-TZUNG; LIU, BU-YUAN; WANG, YI-PING; SUN, ANDY; CHIANG, CHUN-PIN |
| 臺大學術典藏 |
2018-09-10T06:15:34Z |
Oral verruciform xanthoma: A clinicopathologic study of 15 cases
|
Yu, C.-H.;Tsai, T.-C.;Wang, J.-T.;Liu, B.-Y.;Wang, Y.-P.;Sun, A.;Chiang, C.-P.; ANDY SUN |
| 臺大學術典藏 |
2021-07-07T02:13:07Z |
Oral verruciform xanthoma: A clinicopathologic study of 15 cases
|
Yu C.-H.; Tsai T.-C.; Wang J.-T.; Liu B.-Y.; YI-PING WANG; Sun A.; Chiang C.-P. |
| 國立成功大學 |
2023 |
Oral verruciform xanthoma: Case report
|
Hwang, M.-J.;Yu-Fong, Chang J.;Chiang, Chiang C.-P.;Jin, Y.-T. |
| 國立臺灣大學 |
2009 |
Oral Verrucous Hyperplasia: Histologic Classification, Prognosis, and Clinical Implications
|
王逸平; 陳信銘; 郭儒銓; 余權航; 孫安迪; 劉步遠; 郭英雄; 江俊斌; WANG, YI-PING; CHEN, HSIN-MING; KUO, RU- CHENG; YU, CHUAN-HANG; SUN, ANDY; LIU, BU-YUAN; KUO, YING-SHIUNG; CHIANG, CHUN-PIN |
| 臺大學術典藏 |
2021-07-07T02:13:04Z |
Oral verrucous hyperplasia: Histologic classification,prognosis, and clinical implications
|
YI-PING WANG; Chen H.-M.; Kuo R.-C.; Yu C.-H.; Sun A.; Liu B.-Y.; Kuo Y.-S.; Chiang C.-P. |
| 臺大學術典藏 |
2021-10-18T06:51:39Z |
Oral verrucous hyperplasia: Histologic classification,prognosis, and clinical implications
|
Wang Y.-P.; HSIN-MING CHEN; Kuo R.-C.; Yu C.-H.; Sun A.; Liu B.-Y.; Kuo Y.-S.; Chiang C.-P. |
| 國立成功大學 |
2008-07 |
Oral-facial-digital syndrome with vaginal atresia, hydronephrosis and congenital cardiac defect
|
Su, Wei-Ren; Wang, Ping-Hui; Lian, Jenn-Dong; Lin, Mark Chii-Jeng |
| 國家衛生研究院 |
2014-04 |
Orally active microtubule-targeting agent, MPT0B271, for the treatment of human non-small cell lung cancer, alone and in combination with erlotinib
|
Tsai, AC;Wang, CY;Liou, JP;Pai, HC;Hsiao, CJ;Chang, JY;Wang, JC;Teng, CM;Pan, SL |
| 臺北醫學大學 |
2014 |
Orally active microtubule-targeting agent, MPT0B271, for the treatment of human non-small cell lung cancer, alone and in combination with erlotinib
|
AC, Tsai;CY, Wang;JP, Liou;HC, Pai;CJ, Hsiao;JY, Chang;JC, Wang;CM, Teng;SL, Pan |
| 臺北醫學大學 |
2014 |
Orally active microtubule-targeting agent, MPT0B271, for the treatment of human non-small cell lung cancer, alone and in combination with erlotinib
|
Tsai, AC;Wang, CY;Liou, JP;Pai, HC;Hsiao, CJ;Chang, JY;Wang, JC;Teng, CM;Pan, SL. |
| 國立成功大學 |
2014-04 |
Orally active microtubule-targeting agent, MPT0B271, for the treatment of human non-small cell lung cancer, alone and in combination with erlotinib
|
Tsai, A-C; Wang, C-Y; Liou, J-P; Pai, H-C; Hsiao, C-J; Chang, J-Y; Wang, J-C; Teng, C-M; Pan, S-L |
| 國立臺灣大學 |
2014 |
Orally active microtubule-targeting agent, MPT0B271, for the treatment of human non-small cell lung cancer, alone and in combination with erlotinib
|
Tsai, A-C; Wang, C-Y; Liou, J-P; Pai, H-C; Hsiao, C-J; Chang, J-Y; Wang, J-C; Teng, C-M; Pan, S-L; 鄧哲明 |
| 臺北醫學大學 |
1997 |
Orally administered iodinated recombinant human insulin-like growth factor-I (125I-rhIGF-I) is poorly absorbed by the newborn piglet.
|
趙振瑞; Donovan SM; Chao JC-J; Zijlstra RT; and Odle J |
| 實踐大學 |
2011 |
Orally administered mycelial culture of Phellinus linteus exhibits antitumor effects in hepatoma cell-bearing mice
|
Huang, H.Y.;Chieh, S.Y.;Tso, T.K.;Chien, T.Y.;Lin, H.T.;Tsai, Y.C. |
| 亞洲大學 |
2019-08 |
Orally administered resveratrol enhances the therapeutic effect of autologous transplanted adipose-derived stem cells on rats with diabetic hepatopathy
|
Chen, T.-S.;Chen, T.-S.;Lai, C.-H.;Lai, C.-H.;Shen, C.-Y.;Shen, C.-Y.;Pai, P.-Y.;Pai, P.-Y.;Chen, R.-J.;Chen, R.-J.;PadmaVisw, V.;PadmaViswanadha, V.;Yang, C.-K.;Yang, C.-K.;Chen, M.-C.;Chen, M.-C.;Lin, Y.-M.;Lin, Y.-M.;黃志揚;Huang, Chih-Yang |
| 國家衛生研究院 |
2025-02-27 |
Orally bioavailable and site-selective covalent STING inhibitor derived from a macrocyclic marine diterpenoid
|
Niu, GH;Hsiao, WC;Lee, PH;Zheng, LG;Yang, YS;Huang, WC;Hsieh, CC;Chiu, TY;Wang, JY;Chen, CP;Huang, CL;You, MS;Kuo, YP;Wang, CM;Wen, ZH;Yu, GY;Chen, CT;Chi, YH;Tung, CW;Hsu, SC;Yeh, TK;Sung, PJ;Zhang, MZM;Tsou, LK |
| 國家衛生研究院 |
2024-05 |
Orally ingested self-powered stimulators for targeted gut-brain axis electrostimulation to treat obesity and metabolic disorders
|
Mac, CH;Tai, HM;Huang, SM;Peng, HH;Sharma, AK;Nguyen, GLT;Chang, PJ;Wang, JT;Chang, Y;Lin, YJ;Sung, HW |
| 國立交通大學 |
2014-12-08T15:16:03Z |
Orange and red organic light-emitting devices employing neutral Ru(II) emitters: Rational design and prospects for color tuning
|
Tung, Yung-Liang; Chen, Li-Shiuan; Chi, Yun; Chou, Pi-Tai; Cheng, Yi-Ming; li, Ese Y. Li; Lee, Gene-Hsiang; Shu, Ching-Fong; Wu, Tang-Iy; Carty, Arthur J. |
| 國立臺灣大學 |
2006 |
Orange and Red Organic Light-Emitting Devices Employing Neutral Ru(II) Emitters: Rational Design and Prospects for Color Tuning
|
Tung, Y.-L.; Chen, L.-S.; Chi, Y.; Chou, P.-T.; Cheng, Y.-M.; Li, E. Y.; Lee, G.-H.; Shu, C.-F.; Wu, F.-I.; Carty, A. J. |
| 國立臺灣大學 |
2006-08 |
Orange and red organic light-emitting devices employing neutral Ru(II) emitters: Rational design and prospects for color tuning
|
Tung, YL; Chen, LS; Chi, Y; Chou, PT; Cheng, YM; Li, EY; Lee, GH; Shu, CF; Wu, TI; Carty, AJ |
| 臺大學術典藏 |
2018-09-10T05:56:01Z |
Orange and red organic light-emitting devices employing neutral Ru(II) emitters: Rational design and prospects for color tuning
|
Tung, Y.-L.;Chen, L.-S.;Chi, Y.;Chou, P.-T.;Cheng, Y.-M.;Li, E.Y.;Lee, G.-H.;Shu, C.-F.;Wu, F.-I.;Carty, A.J.; Tung, Y.-L.; Chen, L.-S.; Chi, Y.; Chou, P.-T.; Cheng, Y.-M.; Li, E.Y.; Lee, G.-H.; Shu, C.-F.; Wu, F.-I.; Carty, A.J.; PI-TAI CHOU |
| 嘉南藥理大學 |
2011 |
Orange Polymethoxylated Flavones Suppress scavenger Receptor Expression in THP-1 Cells and Alter Lipid homeostasis in HepG2 Liver Cells
|
Jui-Hung Yen (顏瑞鴻); Ching-Yi Weng (翁菁憶); Shiming Li; Ya-Hsuan Lo (駱雅萱); Ming-Hsiung Pan (潘敏雄); Shih-Hang Fu (傅士航); Chi-Tang Ho (何其儻); Ming-Jiuan Wu (吳明娟) |
| 國立政治大學 |
2009 |
Orange 手機維修公司之經營計畫
|
連啟祥; Tony Lien |
| 臺大學術典藏 |
2018-09-10T05:58:02Z |
Orange–Red Light-Emitting Diodes Based on a Prestrained InGaN–GaN Quantum-Well Epitaxy Structure
|
Horng-Shyang Chen; Chih-Feng Lu; Dong-Ming Yeh; Chi-Feng Huang; Jian-Jang Huang; Chih-Chung Yang; JIAN-JANG HUANG; CHIH-CHUNG YANG |
| 臺大學術典藏 |
2006 |
Orange{\\&}ndash$\\mathsemicolon$Red Light-Emitting Diodes Based on a Prestrained {InGaN}{\\&}ndash$\\mathsemicolon${GaN} Quantum-Well Epitaxy Structure
|
Horng-Shyang Chen; Chih-Feng Lu; Dong-Ming Yeh; Chi-Feng Huang; Jian-Jang Huang; Chih-Chung Yang; JIAN-JANG HUANG; CHIH-CHUNG YANG |
| 臺大學術典藏 |
2006 |
Orange–Red Light-Emitting Diodes Based on a Prestrained InGaN–GaN Quantum-Well Epitaxy Structure
|
Chen, Horng-Shyang; Lu, Chih-Feng; Yeh, Dong-Ming; Huang, Chi-Feng; Huang, Jian-Jang; Yang, Chih-Chung; Chen, Horng-Shyang; Lu, Chih-Feng; Yeh, Dong-Ming; Huang, Chi-Feng; Huang, Jian-Jang; Yang, Chih-Chung |
| 國立臺灣大學 |
2006 |
Orange–Red Light-Emitting Diodes Based on a Prestrained InGaN–GaN Quantum-Well Epitaxy Structure
|
Chen, Horng-Shyang; Lu, Chih-Feng; Yeh, Dong-Ming; Huang, Chi-Feng; Huang, Jian-Jang; Yang, Chih-Chung |
| 臺大學術典藏 |
2018-09-10T18:04:58Z |
Orantinib versus placebo combined with transcatheter arterial chemoembolisation in patients with unresectable hepatocellular carcinoma (ORIENTAL): a randomised, double-blind, placebo-controlled, multicentre, phase 3 study
|
Kudo, M.;Cheng, A.-L.;Park, J.-W.;Park, J.H.;Liang, P.-C.;Hidaka, H.;Izumi, N.;Heo, J.;Lee, Y.J.;Sheen, I.-S.;Chiu, C.-F.;Arioka, H.;Morita, S.;Arai, Y.; PO-CHIN LIANG; ANN-LII CHENG |
| 臺大學術典藏 |
2020-08-11T08:36:43Z |
Orantinib versus placebo combined with transcatheter arterial chemoembolisation in patients with unresectable hepatocellular carcinoma (ORIENTAL): a randomised, double-blind, placebo-controlled, multicentre, phase 3 study
|
Kudo M.;Cheng A.-L.;Park J.-W.;Park J.H.;Po-Chin Liang;Hidaka H.;Izumi N.;Heo J.;Lee Y.J.;Sheen I.-S.;Chiu C.-F.;Arioka H.;Morita S.;Arai Y.; Kudo M.; Cheng A.-L.; Park J.-W.; Park J.H.; PO-CHIN LIANG; Hidaka H.; Izumi N.; Heo J.; Lee Y.J.; Sheen I.-S.; Chiu C.-F.; Arioka H.; Morita S.; Arai Y. |
| 臺大學術典藏 |
2021-08-31T06:29:32Z |
Orantinib versus placebo combined with transcatheter arterial chemoembolisation in patients with unresectable hepatocellular carcinoma (ORIENTAL): a randomised, double-blind, placebo-controlled, multicentre, phase 3 study
|
Kudo M.; ANN-LII CHENG; Park J.-W.; Park J.H.; Liang P.-C.; Hidaka H.; Izumi N.; Heo J.; Lee Y.J.; Sheen I.-S.; Chiu C.-F.; Arioka H.; Morita S.; Arai Y. |
| 國立臺灣大學 |
2006 |
Oratorical Manipulation and Critical Reading: A Study of the Proem of Lysias, Against Eratosthenes
|
Vassilis Vagios |
| 國立臺灣海洋大學 |
2000 |
Oratosquillina manningi, a new species of stomatopod from Taiwan and Australia.
|
Shane T. Ahyong;Tin-Yam Chan;Y. J. Liao |
| 國立成功大學 |
2012 |
Orbifold Gromov-Witten theory of the symmetric product of A(r)
|
Cheong, Wan Keng; Gholampour, Amin |
| 嘉南藥理大學 |
2009 |
Orbis
|
Elsevier SDOL |
| 國立成功大學 |
2009-10 |
Orbit accuracy requirement ABYSS: the space station radar altimeter to map global bathymetry
|
Shum, C. K.; Abusali, P. A. M.; Kuo, Chung-Yen; Lee, Hyongki; Ogle, James; Raney, R. Keith; Ries, John C.; Smith, Walter H. F.; Svehla, Drazen; Zhao, Changyin |
| 國立成功大學 |
2009-10 |
Orbit Accuracy Requirement for ABYSS: The Space Station Radar Altimeter to Map Global Bathymetry
|
Shum, C. K.; Abusali, P. A. M.; Kuo, Chung-Yen; Lee, Hyongki; Ogle, James; Raney, R. Keith; Ries, John C.; Smith, Walter H. F.; Svehla, Drazen; Zhao, Changyin |
显示项目 642376-642425 / 2348674 (共46974页)
<< < 12843 12844 12845 12846 12847 12848 12849 12850 12851 12852 > >>
每页显示[10|25|50]项目
|
